Insider Cluster (3 insiders) ·Filed Apr 30, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $1.4M total
Actionable Insight • Neutral

Monitor for upcoming clinical catalysts or regulatory updates, as the selling is small but involves key executives. Any further insider sales could amplify bearish sentiment.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PHVS ▲ +9.55% at T+60d
NEUTRAL call ✓ call won +9.55% · α vs SPY +6.44% · entry $31.01 → $33.97
Entry anchored
Apr 29, 03:59 PM ET
via exchange tick
T+1d
-5.06%
call -5.06% · α -5.28%
$29.44
settled 5mo ago
T+5d
-2.90%
call -2.90% · α -4.63%
$30.11
settled 5mo ago
T+20d
-3.71%
call -3.71% · α -8.68%
$29.86
settled 4mo ago
T+60d
+9.55%
call +9.55% · α +6.44%
$33.97
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three Pharvaris insiders (CMO, Chief Early Development, Director) sold a combined ~$2.19M in open-market transactions over the past week, representing 0.11% of market cap. Sales are modest relative to company size but involve senior officers, warranting monitoring.

Key Financial Metrics

Direction
selling
Total Value
$2.2M
Insiders
3

Key Facts

  • Lu Peng (CMO) sold ~$989K across three separate trades.
  • Lesage Anne (Chief Early Development) sold ~$223K in two trades.
  • Schikan Johannes (Director) sold ~$976K in two trades.
  • Total open-market sales: ~$2.19M (0.11% of $2.0B market cap).
  • All sales were preceded by option exercises at nominal prices, typical for tax or profit-taking.

Financial Impact

$2.19 million in insider sales over 7 days

Risk Factors

  • Continued insider selling may signal low confidence ahead of news.
  • No clear catalyst identified—selling may be pre-planned or tax-related.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1778010710838
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 5, 2026